Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauri Aaltonen

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancer|May 7, 2003
Subsequent primary malignancies after endometrial carcinoma and ovarian carcinomaKari Hemminki, Lauri Aaltonen, Xinjun Li
The Journal of Pathology|June 26, 2002
Does MSI-low exist?Ian Tomlinson, Sarah Halford, Lauri Aaltonen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumorsLauri Aaltonen, Louise Johns, Heikki Järvinen, et al.
Nature Communications|September 1, 2023
Transposable elements as tissue-specific enhancers in cancers of endodermal lineageKonsta Karttunen, Divyesh Patel, Jihan Xia, et al.
The American Journal of Surgical Pathology|April 15, 2022
Histopathologic and Molecular Characterization of Uterine Leiomyoma-like Inflammatory Myofibroblastic Tumor: Comparison to Molecular Subtypes of Uterine LeiomyomaHeli Kuisma, Vilja Jokinen, Annukka Pasanen, et al.
Scientific Reports|January 1, 2021
Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancerVeronica Rendo, Snehangshu Kundu, Natallia Rameika, et al.
Human Mutation|April 23, 2002
Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindredCarla Oliveira, Maria Cristina Bordin, Nicola Grehan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Molecular staging for survival prediction of colorectal cancer patientsSteven Eschrich, Ivana Yang, Greg Bloom, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 8, 2013
HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer riskVirpi H Laitinen, Tiina Wahlfors, Leena Saaristo, et al.
Cell Host & Microbe|December 20, 2011
KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transitionFang Cheng, Pirita Pekkonen, Simonas Laurinavicius, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer|May 7, 2003
Subsequent primary malignancies after endometrial carcinoma and ovarian carcinomaKari Hemminki, Lauri Aaltonen, Xinjun Li
The Journal of Pathology|June 26, 2002
Does MSI-low exist?Ian Tomlinson, Sarah Halford, Lauri Aaltonen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumorsLauri Aaltonen, Louise Johns, Heikki Järvinen, et al.
Nature Communications|September 1, 2023
Transposable elements as tissue-specific enhancers in cancers of endodermal lineageKonsta Karttunen, Divyesh Patel, Jihan Xia, et al.
The American Journal of Surgical Pathology|April 15, 2022
Histopathologic and Molecular Characterization of Uterine Leiomyoma-like Inflammatory Myofibroblastic Tumor: Comparison to Molecular Subtypes of Uterine LeiomyomaHeli Kuisma, Vilja Jokinen, Annukka Pasanen, et al.
Scientific Reports|January 1, 2021
Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancerVeronica Rendo, Snehangshu Kundu, Natallia Rameika, et al.
Human Mutation|April 23, 2002
Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindredCarla Oliveira, Maria Cristina Bordin, Nicola Grehan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Molecular staging for survival prediction of colorectal cancer patientsSteven Eschrich, Ivana Yang, Greg Bloom, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 8, 2013
HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer riskVirpi H Laitinen, Tiina Wahlfors, Leena Saaristo, et al.
Cell Host & Microbe|December 20, 2011
KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transitionFang Cheng, Pirita Pekkonen, Simonas Laurinavicius, et al.
Pageof 2